Distinct microRNA expression profiles in mouse renal cortical tissue after 177Lu-octreotate administration

Emil Schüler1, Toshima Z Parris2, Khalil Helou2

  • 1Department of Radiation Physics, Institute of Clinical Sciences, Sahlgrenska Cancer Center, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

Plos One
|November 12, 2014
PubMed
Abstract

Insights

This study investigated microRNA (miRNA) expression in kidney tissue after 177Lu-octreotate treatment for neuroendocrine cancers. Results show dose-specific miRNA changes, suggesting their role in early kidney immune responses to radiation.

Area of Science:

  • Oncology
  • Radiopharmaceuticals
  • Molecular Biology

Background:

  • 177Lu-octreotate is a radiopharmaceutical used for neuroendocrine cancer treatment.
  • Understanding its effects on normal tissues, like the kidney, is crucial for patient safety.
  • MicroRNAs (miRNAs) are key regulators of gene expression and can be affected by radiation.

Purpose of the Study:

  • To investigate changes in miRNA expression in normal renal cortical tissue following 177Lu-octreotate administration.
  • To identify specific miRNAs that are differentially regulated in response to varying doses of 177Lu-octreotate.
  • To explore the functional implications of these miRNA changes in kidney tissue.

Main Methods:

  • Female BALB/c nude mice were administered different doses of 177Lu-octreotate or saline (control).
  • Renal cortical tissue was collected 24 hours post-injection.
  • Total RNA and miRNA were extracted and analyzed using a Mouse miRNA Oligo chip to identify differentially expressed miRNAs.

Main Results:

  • 57 specific miRNAs were found to be differentially regulated in kidney tissue across different radiation doses.
  • MiRNA regulation was generally dose-specific, with some miRNAs commonly regulated at higher doses.
  • Thirty-nine of the regulated miRNAs are known to be associated with response to ionizing radiation, indicating conserved radiation-responsive pathways.
  • Significant effects on cellular mechanisms, including immune response and p53 signaling, were observed at the highest dose.

Conclusions:

  • 177Lu-octreotate administration leads to dose-specific miRNA expression signatures in renal tissue.
  • These findings highlight the transcriptional regulation of radiation-responsive miRNAs.
  • The results suggest that miRNAs play a significant role in early immunological responses within the kidneys after 177Lu-octreotate treatment.